| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6199195 | Ophthalmology | 2016 | 7 Pages |
Abstract
This study compared the outcomes of VEC chemotherapy with a 5-drug combination of vincristine and carboplatin, alternating with cyclophosphamide, idarubicin, and vincristine, for stage III retinoblastoma. The VEC combination was found to be more effective and may be recommended as neoadjuvant and adjuvant chemotherapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Bhavna MS, Fahmi PhD, Rachna DNB, Sushmita MD, Rajesh MD, Sanjay MD, Ashish MA, Rajvardhan MD,